Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
N. Lynn Henry(University of Michigan), Daniel J. Clauw(University of Michigan), Dina Dadabhoy(University of Michigan), Penny Powers(Parkland Health & Hospital System), Suzanne Lemler, Jill A. Hayden(Northwestern University), Anna Maria Storniolo(Indiana University Health), Vered Stearns(Johns Hopkins University), Daniel F. Hayes(University of Michigan–Ann Arbor), Monika Mohan(University of Michigan), Jon T. Giles(Cedars-Sinai Medical Center), Lang Li(Sun Yat-sen University), Dennis C. Ang(University School), Karineh Shahverdi(Johns Hopkins University), David A. Flockhart(Indiana University – Purdue University Indianapolis), Jason Robarge(Washington University in St. Louis)
Cited by 238
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity
|Arthritis Care & Research|2010|3.9k